Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Sharp Drop in Opioid Prescriptions Raises Questions Over Other Drugs
Opioid prescribing in workers compensation nosedived to an all-time low last year, a new report finds, but experts say there are concerns with other drugs being used for pain management.
Aviva Canada Selects Mitchell Solutions to Help Streamline Claims Management
SAN DIEGO, Calif.— Mitchell, an Enlyte company and leading technology and information provider for the Property and Casualty (P&C) claims and Collision Repair industries, today announced that Aviva Canada has implemented its full suite of enterprise claims management solutions.
Unlocking the DME “Black Box”
CDC Updates and Replaces Guidelines for Prescribing Opioids
The Centers for Disease Control and Prevention (CDC) released an updated and expanded recommendation for clinicians prescribing opioids for outpati
The Impact of Resilience on Recovery from Injury or Illness
A key component of resilience is optimism, a hopeful, positive outlook on the future and the world around us.
Ask The Pharmacist: Traveling With a Controlled Substance Prescription Medication
Are there rules or recommendations for traveling with a controlled substance?